These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Left ventricular assist device as destination therapy: application of the payment-by-results approach for the device reimbursement. Messori A; Trippoli S; Bonacchi M; Sani G J Thorac Cardiovasc Surg; 2009 Aug; 138(2):480-5. PubMed ID: 19619799 [TBL] [Abstract][Full Text] [Related]
9. Ventricular assist device programs: design and function. Van Meter CH; Hollenbach Ordoyne SK; Kateiva JE Ann Thorac Surg; 1999 Aug; 68(2):643-5. PubMed ID: 10475463 [TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness analysis of continuous-flow left ventricular assist devices as destination therapy. Rogers JG; Bostic RR; Tong KB; Adamson R; Russo M; Slaughter MS Circ Heart Fail; 2012 Jan; 5(1):10-6. PubMed ID: 22052901 [TBL] [Abstract][Full Text] [Related]
11. Why is There Discordance between the Reimbursement of High-Cost 'Life-Extending' Pharmaceuticals and Medical Devices? The Funding of Ventricular Assist Devices in Australia. Saing S; van der Linden N; Hayward C; Goodall S Appl Health Econ Health Policy; 2019 Aug; 17(4):421-431. PubMed ID: 30906972 [TBL] [Abstract][Full Text] [Related]
12. Heart transplant and left ventricular assist device costs. Digiorgi PL; Reel MS; Thornton B; Burton E; Naka Y; Oz MC J Heart Lung Transplant; 2005 Feb; 24(2):200-4. PubMed ID: 15701438 [TBL] [Abstract][Full Text] [Related]
13. Medicare reimbursement for destination therapy: the right decision at the right time? Mussivand T Artif Organs; 2004 Jun; 28(6):523-5. PubMed ID: 15153142 [No Abstract] [Full Text] [Related]
14. Hospitalization charges, costs, and income for firearm-related injuries at a university trauma center. Kizer KW; Vassar MJ; Harry RL; Layton KD JAMA; 1995 Jun; 273(22):1768-73. PubMed ID: 7769771 [TBL] [Abstract][Full Text] [Related]
15. Clinical experience with the Novacor ventricular assist system. Bridge to transplantation and the transition to permanent application. McCarthy PM; Portner PM; Tobler HG; Starnes VA; Ramasamy N; Oyer PE J Thorac Cardiovasc Surg; 1991 Oct; 102(4):578-86; discussion 586-7. PubMed ID: 1921434 [TBL] [Abstract][Full Text] [Related]
16. Left ventricular assist devices as permanent heart failure therapy: the price of progress. Oz MC; Gelijns AC; Miller L; Wang C; Nickens P; Arons R; Aaronson K; Richenbacher W; van Meter C; Nelson K; Weinberg A; Watson J; Rose EA; Moskowitz AJ Ann Surg; 2003 Oct; 238(4):577-83; discussion 583-5. PubMed ID: 14530729 [TBL] [Abstract][Full Text] [Related]
17. Preoperative predictors of survival in patients with Thoratec ventricular assist devices as a bridge to heart transplantation. Thoratec Ventricular Assist Device Principal Investigators. Farrar DJ J Heart Lung Transplant; 1994; 13(1 Pt 1):93-100; discussion 100-1. PubMed ID: 8167132 [TBL] [Abstract][Full Text] [Related]
18. State of the art. Circulatory support. Kantrowitz A ASAIO Trans; 1988; 34(3):445-9. PubMed ID: 3058180 [TBL] [Abstract][Full Text] [Related]
19. Summary of the clinical use of the Symbion total artificial heart: a registry report. Johnson KE; Prieto M; Joyce LD; Pritzker M; Emery RW J Heart Lung Transplant; 1992; 11(1 Pt 1):103-16. PubMed ID: 1540598 [TBL] [Abstract][Full Text] [Related]
20. Costs associated with ventricular assist device use in children. Mahle WT; Ianucci G; Vincent RN; Kanter KR Ann Thorac Surg; 2008 Nov; 86(5):1592-7. PubMed ID: 19049755 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]